# Impact of Inhaled PT003 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient

> **NCT04087590** · PHASE2 · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 4 (actual)

## Conditions studied

- Copd

## Interventions

- **DRUG:** Formoterol-glycopyrronium co suspension (PT003)

## Key facts

- **NCT ID:** NCT04087590
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-14
- **Primary completion:** 2023-03-23
- **Final completion:** 2023-03-23
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Following Brexit and the unavailability of the experimental drug (PT003) in France, the study was terminated prematurely.
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087590, "Impact of Inhaled PT003 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04087590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*